Symbol | Company | Weighting |
---|---|---|
RNA | AVIDITY BIOSCIENCES INC | 2.32% |
IONS | IONIS PHARMACEUTICALS INC | 2.16% |
DYN | DYNE THERAPEUTICS, INC. | 2.14% |
SRPT | SAREPTA THERAPEUTICS INC | 2.01% |
AKRO | AKERO THERAPEUTICS INC | 1.98% |
ISRG | INTUITIVE SURGICAL INC | 1.95% |
ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 1.92% |
REGN | REGENERON PHARMACEUTICALS | 1.90% |
DNLI | DENALI THERAPEUTICS INC. | 1.90% |
ARGX | ARGENX SE ADR | 1.89% |
MCK | MCKESSON CORP | 1.84% |
NVO | NOVO NORDISK A/S | 1.81% |
RYTM | RHYTHM PHARMACEUTICALS INC | 1.81% |
ITCI | INTRA-CELLULAR THERAPIES USD | 1.79% |
NUVL | NUVALENT INC | 1.79% |
BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.78% |
EW | EDWARDS LIFESCIENCES CORP | 1.77% |
ARWR | ARROWHEAD PHARMACEUTICALS INC | 1.76% |
VRTX | VERTEX PHARMACEUTICALS INC | 1.74% |
NTRA | NATERA INC | 1.73% |
ACHC | ACADIA HEALTHCARE CO INC | 1.72% |
SYK | STRYKER CORP | 1.72% |
BSX | BOSTON SCIENTIFIC | 1.72% |
ELV | ELEVANCE HEALTH INC | 1.71% |
SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.71% |
LNTH | LANTHEUS HOLDINGS INC | 1.69% |
AZN | ASTRAZENECA PLC-ADR | 1.69% |
PCVX | VAXCYTE INC | 1.68% |
TEVA | TEVA PHARMACEUTICAL INDS LTD | 1.68% |
ALKS | ALKERMES INC | 1.68% |
SNY | SANOFI- AVENTIS- ADR | 1.67% |
NBIX | NEUROCRINE BIOSCIENCES INC | 1.66% |
RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.65% |
ZTS | ZOETIS INC | 1.65% |
LLY | ELI LILLY CORP | 1.64% |
BDX | BECTON DICKINSON & CO | 1.63% |
HCA | HCA HOLDINGS INC | 1.63% |
BIIB | BIOGEN INC | 1.62% |
UNH | UNITEDHEALTH GROUP INC | 1.60% |
AMGN | AMGEN CORP | 1.58% |
DHR | DANAHER CORP | 1.57% |
MRK | MERCK & CO. NEW | 1.57% |
CRL | CHARLES RIVER LABORATORIES INT INC | 1.57% |
KURA | KURA ONCOLOGY INC | 1.57% |
APLS | APELLIS PHARMACEUTICALS INC | 1.56% |
IDXX | IDEXX LABS CORP | 1.53% |
CYTK | CYTOKINETICS INC | 1.52% |
IMVT | IMMUNOVANT INC | 1.45% |
WST | WEST PHARMACEUTICAL SERVICES INC | 1.45% |
DXCM | DEXCOM INC | 1.44% |
TNDM | TANDEM DIABETES CARE INC | 1.44% |
INSP | INSPIRE MEDICAL SYSTEMS, INC. | 1.44% |
AVTR | AVANTOR, INC. | 1.42% |
EXAS | EXACT SCIENCES CORP | 1.40% |
XNCR | XENCOR INC. | 1.38% |
ARVN | ARVINAS INC USD | 1.38% |
TMO | THERMO FISHER SCIENTIFIC INC | 1.37% |
VKTX | VIKING THERAPEUTICS, INC. | 1.32% |
TARS | TARSUS PHARMACEUTICALS | 1.20% |
SRRK | SCHOLAR ROCK HLDG CORP USD | 1.12% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2024 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.